Systemic immunosuppressive drug therapy

Non-Hodgkin's Lymphoma - Systemic immunosuppressive drug therapy Factor

Last reviewed for CCPS 17 December 2003.

Investigative Documents

Medical Report - Systemic Immunosuppressive Drug Therapy - Non-Hodgkin's Lymphoma [MR9214]

Preliminary questions [8075]

8596

there is some evidence that systemic immunosuppressive drug therapy may be a factor in the development of the condition under consideration.

8083 — the veteran has suffered from a condition specified for non-Hodgkin's lymphoma requiring immunosuppressive drug therapy at some time.

10034 the veteran has rheumatoid arthritis.

or

8615 the veteran has had Sjogren's syndrome at some time.

or

10060 the veteran has had dermatitis herpetiformis at some time.

or

28415 the veteran has suffered from chronic glomerulonephritis at some time.

or

4583 the veteran has suffered from psoriasis at some time.

or

2576

the veteran has had systemic lupus erythematosus at some time.

or

806

the veteran has had ulcerative colitis.

or

3717

the veteran has Crohn's disease.

8084 the veteran received systemic immunosuppressive drug therapy for the identified illness or injury.

8085

the veteran received systemic immunosuppressive drug therapy for the identified illness or injury within the 10 years immediately before the clinical onset of the condition under consideration.

8086 — the veteran has established the causal connection between the systemic immunosuppressive drug therapy and VEA service for the clinical onset of non-Hodgkin's lymphoma.

8087 — the veteran has established the causal connection between the systemic immunosuppressive drug therapy and operational service for the clinical onset of non-Hodgkin's lymphoma.

or

8088 — the veteran has established the causal connection between the systemic immunosuppressive drug therapy and eligible service for the clinical onset of non-Hodgkin's lymphoma.

Clinical onset and operational service [8087]

8089 — the identified illness or injury for which the systemic immunosuppressive drug therapy was given is causally related to operational service.

Clinical onset and eligible service [8088]

8090 — the identified illness or injury for which the systemic immunosuppressive drug therapy was given is causally related to eligible service.